STRAVINSKY stands for ‘Stratification of Clinically Vulnerable People for COVID-19 Risk Using Antibody Testing’. It is a new 2-year study which aims to establish if antibody testing can identify who remains at greatest risk of severe COVID-19 infection after vaccinations. It is funded by National Institute for Health and Care Research (NIHR).
Below you can watch a webinar that took place on 24 April 2024, in which STRAVINSKY study lead Professor Alex Richter gives an update on progress so far.
Find out more about the aims of STRAVINSKY and who is involved.
Meet the researchers who are leading the STRAVINSKY study
Find out more about our participant recruitment and what's involved when you sign up to take part in STRAVINSKY.
Learn more about how participants are directly involved in our research.
Extra resources for participants to provide more information on taking part in STRAVINSKY study.
Stay up-to-date
Sign up to receive our e-newsletter
Follow us on X/Twitter: @STRAVINSKYstudy
If you would like to contact the STRAVINSKY team, please email stravinsky@contacts.bham.ac.uk
STRAVINSKY is funded by:
STRAVINSKY is supported by:
